Overview Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453 Status: Completed Trial end date: 2008-07-01 Target enrollment: Participant gender: Summary The purpose of this study is to assess the tolerability of BIA 5-453 after six multiple rising dose regimens of BIA 5-453. Phase: Phase 1 Details Lead Sponsor: Bial - Portela C S.A.